Want to join the conversation?
$BAX 2Q15 Call: Medical Products sales were in line with our expectations, while strong growth across the BioSceince portfolio contributed the over achievement. Sale in US increased 1% or 5% after adjusting for cyclophosphamide. International sales on constant currency basis increased 4%.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.
$SPY can the rally continue? La Pen almost assured to lose makes me cautious about the results, not a place to panic. If 2400 is reached I'm selling my puts and going for broke. Happy hunting.